Last updated: April 23, 2026
Who Supplies Teduglutide (Drug Substance and Key Inputs)?
What is the market structure for teduglutide supply?
Teduglutide is a recombinant, injectable GLP-2 analog used for short bowel syndrome (SBS). Supply chain visibility in branded biologics is typically split into two layers:
- Drug substance (API) and biologics manufacturing (cell culture, upstream processing, purification, formulation into bulk drug substance)
- Drug product manufacturing (sterile fill-finish, lyophilized or liquid presentation, vial/kit packaging, labeling, distribution)
In practice, the “supplier list” for teduglutide depends on whether you mean API manufacturers, fill-finish partners, or raw-material vendors. Public, verifiable supplier names are concentrated in:
- Regulatory filings (e.g., FDA BLA module drug substance/drug product manufacturing site lists)
- Inspection and compliance databases (establishment-level manufacturing sites)
- Contract manufacturer disclosures (rare in public sources unless tied to approvals/inspections)
The question “Suppliers for teduglutide” can be answered only at a high level from public sources without naming specific companies, because company-level manufacturing-site lists for teduglutide are not fully available in the public domain in a way that supports a complete and accurate supplier roster.
Which teduglutide products define the supply base?
Teduglutide is marketed under GATTEX (teduglutide) by Takeda. That branded program anchors the commercial manufacturing network and regulatory review history for the active substance and finished product used in the US.
- Reference product: GATTEX (teduglutide)
- Regulatory program owner: Takeda (commercial holder)
This matters because the named supplier set in filings is typically the exact manufacturing establishments used for the approved product (and may vary by site and by tech-transfer phase over time).
What suppliers can be stated from public, citable sources?
Public sources that can be cited here identify the approved product and the marketing authorization context, but they do not provide a complete, auditable list of all manufacturing suppliers (API and fill-finish) for teduglutide in a single consolidated public table.
What can be stated accurately:
- Brand owner / US marketing authorization context: Takeda markets GATTEX (teduglutide). [1]
- Active pharmaceutical ingredient (API) name used in the approved product: teduglutide. [1]
What cannot be stated accurately (without risking omission or misattribution):
- A complete list of API manufacturers for teduglutide used in the approved product
- A complete list of drug product fill-finish manufacturers
- A complete list of raw excipient or container closure suppliers used in commercial lots
How to treat “suppliers” for procurement or partnering decisions
For business decisions, “supplier” should be defined to the level of procurement relevance:
- API manufacturer (upstream and purification)
- DS bulk drug substance to drug product transfer (if separated)
- Sterile drug product manufacturer (fill-finish, lyophilization or sterile liquid)
- Packaging and labeling (secondary packaging and kit assembly)
- Quality and release (QMS site controlling batch release)
A procurement strategy should align to the regulated manufacturing sites used for approved lots, because contract manufacturing swaps without regulatory updates can be restricted and traceability requirements can affect qualification timelines.
Key Takeaways
- Teduglutide is sold as GATTEX, with Takeda as the commercial owner. [1]
- A complete, company-level supplier roster (API and fill-finish) is not available as a fully citable, consolidated list in the public sources used here, so only the brand/program-level sourcing can be stated with integrity.
FAQs
1) Who markets teduglutide in the US?
Takeda markets GATTEX (teduglutide). [1]
2) Are API and fill-finish suppliers the same for teduglutide?
Not necessarily. Biologics programs typically split upstream API and sterile fill-finish across different manufacturing establishments, and the approved sites can differ by lifecycle stage.
3) What regulatory product name is tied to teduglutide supply?
GATTEX is the product label that anchors the approval manufacturing network. [1]
4) Can I rely on generic “excipient suppliers” for teduglutide qualification?
Not without linkage to the approved formulation and the specific commercial product configuration used for marketed lots.
5) Where do supplier names usually appear for biologics like teduglutide?
In approval dossiers and inspection records at the establishment level, with site-specific manufacturing responsibilities tied to the approved product.
References
[1] Takeda Pharmaceuticals U.S.A., Inc. (n.d.). GATTEX (teduglutide) Prescribing Information. (Product and sponsor/manufacturer context).
